Identify and understand important and diverse types of therapeutics under development for Indolent Lymphoma
Overall, the combination of IL-21 with Rituxan was well tolerated in patients with relapsed and refractory indolent lymphoma
and was associated with an ORR of 38%.
The goal of treating patients with indolent lymphomas
is to keep them disease-free and treatment-free for as long as possible.
are usually not curable and are treated with palliative therapy.
PET scanning is useful in disease detection in most Hodgkin lymphoma variants especially the aggressive and highly aggressive NHL variants, while its overall usefulness in the indolent lymphomas
In contrast, patients with follicular and other indolent lymphomas
can sustain prolonged remission periods, but eventually relapse and require subsequent courses of therapy that lead to fewer and shorter remissions .
Bendamustine Plus Rituximab Is Superior in Respect of Progression Free Survival and CR Rate When Compared to CHOP Plus Rituximab as First-Line Treatment of Patients with Advanced Follicular, Indolent, and Mantle Cell Lymphomas: Final Results of a Randomized Phase III Study of the StiL (Study Group Indolent Lymphomas
, Germany) Blood (ASH Annual Meeting Abstracts) 2009 Nov;114:405.